Home / Import refusals / AEK-8844325-1/11/1

FDA Import Refusal AEK-8844325-1/11/1 — Inventia Healthcare Limited

Inventia Healthcare Limited — FEI 3008232264

The FDA refused shipment AEK-8844325-1/11/1 from Inventia Healthcare Limited (India) on March 12, 2021. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 12, 2021
Country
India
Product Category
Drugs and Biologics
Product Code
61PDA26 METFORMIN (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1262970 (VAI Wed Feb 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1096293 (VAI Fri Jul 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944555 (NAI Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 833331 (NAI Fri May 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-5296952-4/31/1 (Thu Oct 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8927791-6/11/1 (Thu Sep 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7617729-1/71/1 (Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7622476-2/41/1 (Wed Jul 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7533680-7/11/1 (Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources